Company Profile

SMS LIFESCIENCES INDIA LTD.

NSE : SMSLIFEBSE : 540679ISIN CODE : INE320X01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE712.55-6.6 (-0.92 % )
PREV CLOSE (Rs.) 719.15
OPEN PRICE (Rs.) 720.85
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 584
TODAY'S LOW / HIGH (Rs.)711.00 722.30
52 WK LOW / HIGH (Rs.)470.1 885.8
NSE714.60 -5.55 (-0.77 % )
PREV CLOSE(Rs.) 720.15
OPEN PRICE (Rs.) 721.35
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 7319
TODAY'S LOW / HIGH(Rs.) 710.10 724.80
52 WK LOW / HIGH (Rs.)469.75 885.65

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 4.18071
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) 3.24
ROCE (%) 11.73
Incorporation Year : 2006

Management Info :

- Chairman TVVSN Murthy - Managing Director

Registered Office :

Address : Plot No 19 – I I I, Road No 71,Opp. Bharatiya Vidya Bhavan Public School,Jubilee Hills,
Hyderabad,
Telangana-500096

Phone : 91-040-6628-8888

Website : www.smslife.in

Registrar's Details : Aarthi Consultants Pvt Ltd
1-2-285 ,Domalaguda,,Hyderabad
Listing : BSE, NSE
NEWS More
27Aug08-27-2021$Appointment of Director Appointment of Director
Inter alia, to consider the following: i) approval of the Board Report for the year 2020-21, ii) fixing the date of 15th Annual General Meeting, iii) appointment of Director, iv) any other items as may be decided by the Board of Directors.
Inter alia, to consider the following: i) approval of the Boar..
09Aug08-09-2021$ Board Meeting Intimation for Considering Financial Results Of Quarter Ended June 30, 2021. Board Meeting Intimation fo
SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 ,inter alia, to consider and approve i) Unaudited financial results (Standalone a nd Consolidated) of the Company for the first quarter ended June 30, 2021 . ii) The request received from Promoter/Promoter Group regarding reclassification to Public category pursuant to Regulation 31 (A) of SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015. iii) any other items as may be decided by the Board of Directors.
SMS Lifesciences India Ltdhas informed BSE that the meeting of..
21Jun06-21-2021$ Announcement under Regulation 30 (LODR)-Resignation of Director Announcement under Regulati
We hereby inform that Mr. Ramesh Babu Potluri has conveyed his decision to resign from the position of Non-Executive Director of the Company with immediate effect. The Board of Directors approved the same with effect from the close of business hours on June 18, 2021.
We hereby inform that Mr. Ramesh Babu Potluri has conveyed his..
21Jun06-21-2021$ Reappointment Of Auditor(S) Reappointment Of Auditor(S)
Board of Directors of the Company, at its Meeting held yesterday i.e, June 18, 2021 has approved the REAPPOINTMENT of following Auditors: 1. Statutory Auditors for the Second Term of 5 (five) years 2. Secretarial Auditors for the year 2021-22 3. Cost Auditors for the year 2021 -22
Board of Directors of the Company, at its Meeting held yesterda..
19Jun06-19-2021$SMS Lifesciences India informs about reappointment of auditor(s) SMS Lifesciences India infor

SMS Lifesciences has informed that the Board of Directors of the Company, at its Meeting held yesterday June 18, 2021 has approved the reappointment of following Auditors: Statutory Auditors for the Second Term of 5 (five) years, Secretarial Auditors for the year 2021-22; and Cost Auditors for the year 2021-22.

The above information is a part of company’s filings submitted to BSE.

SMS Lifesciences has informed that the Board of Directors of th..
Financials More
Rs. in Millions
QTR Jun 21 ANNUAL 21
Net Profit28.9800000000001131.69
Gross Profit 41.0800000000001 193.55
Operating Profit 71.4400000000001310.68
Net Sales 732.252602.56
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
JB Chem & Pharma (BSE)
 1836.10 (5.26%)
M.Cap ( in Cr)
14172.76
Alkem Laboratories (BSE)
 4001.85 (0.95%)
M.Cap ( in Cr)
47848.12
Kwality Pharma (BSE)
 688.70 (4.99%)
M.Cap ( in Cr)
714.61
Hester Biosciences (BSE)
 2518.75 (0.91%)
M.Cap ( in Cr)
2133.10
Procter&Gamble Healt (BSE)
 5381.55 (0.34%)
M.Cap ( in Cr)
8915.53
Shareholding Pattern More
PROMOTERS 67.74 %
NON-INSTITUTION 32.26 %
MUTUAL FUNDS/UTI 0 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS
Scheme NameHold(%)
No Data Found
F & O Quotes